Academic Health Center

Center for Drug Design



aHCCDD2 - Content - Image - Logo Tagline Border 700x190px

The research conducted at CDD includes design, discovery and development of therapeutics for various conditions affecting human health. These diverse conditions include cancer, neurological disorders, viral diseases etc. Along with a proven track record of success in developing compounds of medicinal interest (carbovir and abacavir), CDD has added more drug candidates to its growing repertoire. Sulfanegen, an anti-cyanide prevention and treatment agent, is being developed in collaboration with Vytara Pharma Inc, a California based company. In another significant development, several cosmetic companies have shown interest in the 'CDD Functional Cosmetic' compound for the prevention and boost in activation of skin rejuvenating enzymes for people suffering from, or susceptible to, various forms of skin cancers.

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on May 7, 2012